Mariska Hargitay was compensated for her time.
For Mariska Hargitay, it’s personal.
Nearly two decades after losing her father Mickey to multiple myeloma, the Emmy Award-winning actor, director, producer and advocate Mariska is finally confronting the questions she couldn’t ask then.
Now, with a renewed drive for answers, she is shining a light on his story, this complex disease and the investigational approaches that have emerged since his passing, like CELMoD research.
My father, Mickey Hargitay, was my mentor and my North star. My hope is that by sharing my father’s story and highlighting CELMoD research, that I can help educate on multiple myeloma and inspire other people that are impacted by this disease to not give up.
Science doesn’t stand still — and neither does the search for answers. CELMoD research is an investigational approach that targets specific proteins involved in multiple myeloma. See how it works in our mechanism of action video.
This video requires JavaScript to play.
Multiple Myeloma:
Multiple myeloma is a cancer that affects the blood and bones. It’s the second most common blood cancer in the U.S.—yet many people have never heard of it until a diagnosis hits close to home.
Understanding the disease is an important first step.
Learn More About Multiple Myeloma
